{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:27Z","timestamp":1786982247616,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation of Korea grant","doi-asserted-by":"crossref","award":["2017R1A5A2015369, 2018R1C1B5044890 and 2020R1F1A1072449"],"award-info":[{"award-number":["2017R1A5A2015369, 2018R1C1B5044890 and 2020R1F1A1072449"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12072-021-10160-3","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T06:29:42Z","timestamp":1618554582000},"page":"424-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study"],"prefix":"10.1007","volume":"15","author":[{"given":"Seong Hee","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-2206","authenticated-orcid":false,"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek Gyu","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Tae","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Don","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gab Jin","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Koo","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"issue":"25","key":"10160_CR1","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJM199406233302515","volume":"330","author":"E Montero","year":"1994","unstructured":"Montero E, Miguel J, Lopez-Alvarez J. Care of patients with ascites. N Engl J Med. 1994;330(25):1828.","journal-title":"N Engl J Med"},{"issue":"7","key":"10160_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","volume":"61","author":"A Krag","year":"2012","unstructured":"Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease. Gut. 2012;61(7):967\u20139.","journal-title":"Gut"},{"issue":"5","key":"10160_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8(5):1151\u20137.","journal-title":"Hepatology"},{"issue":"2","key":"10160_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cld.2013.12.003","volume":"18","author":"A Berzigotti","year":"2014","unstructured":"Berzigotti A, Bosch J. Pharmacologic management of portal hypertension. Clin Liver Dis. 2014;18(2):303\u201317.","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"10160_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12072-017-9806-1","volume":"12","author":"SH Kang","year":"2018","unstructured":"Kang SH, Kim MY, Baik SK. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon. Hepatol Int. 2018;12(Suppl 1):112\u201321.","journal-title":"Hepatol Int"},{"issue":"Suppl 1","key":"10160_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12072-017-9833-y","volume":"12","author":"A Baiges","year":"2018","unstructured":"Baiges A, Hernandez-Gea V, Bosch J. Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol Int. 2018;12(Suppl 1):68\u201380.","journal-title":"Hepatol Int"},{"issue":"6","key":"10160_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/0016-5085(95)90759-9","volume":"109","author":"S Moller","year":"1995","unstructured":"Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 1995;109(6):1917\u201325.","journal-title":"Gastroenterology"},{"issue":"6","key":"10160_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/0016-5085(89)90396-X","volume":"97","author":"JH Henriksen","year":"1989","unstructured":"Henriksen JH, Bendtsen F, Sorensen TI, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology. 1989;97(6):1506\u201313.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10160_CR9","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0168-8278(05)80451-9","volume":"17","author":"V Arroyo","year":"1993","unstructured":"Arroyo V, Gines P. Mechanism of sodium retention and ascites formation in cirrhosis. J Hepatol. 1993;17(Suppl 2):S24-28.","journal-title":"J Hepatol"},{"issue":"1","key":"10160_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3350\/cmh.2017.0064","volume":"24","author":"YS Seo","year":"2018","unstructured":"Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol. 2018;24(1):20\u201342.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10160_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3350\/cmh.2014.20.4.376","volume":"20","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim JM, Cho YZ, et al. Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension. Clin Mol Hepatol. 2014;20(4):376\u201383.","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10160_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serste","year":"2010","unstructured":"Serste T, Melot C, Francoz C, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52(3):1017\u201322.","journal-title":"Hepatology"},{"key":"10160_CR13","unstructured":"Korean Association for the Study of the L. KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020"},{"issue":"1","key":"10160_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","volume":"44","author":"S Nagula","year":"2006","unstructured":"Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol. 2006;44(1):111\u20137.","journal-title":"J Hepatol"},{"issue":"3","key":"10160_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743\u201352.","journal-title":"J Hepatol"},{"issue":"4","key":"10160_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/hep.30220","volume":"69","author":"M Sharma","year":"2019","unstructured":"Sharma M, Singh S, Desai V, et al. Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis. Hepatology. 2019;69(4):1657\u201375.","journal-title":"Hepatology"},{"issue":"10181","key":"10160_CR17","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","volume":"393","author":"C Villanueva","year":"2019","unstructured":"Villanueva C, Albillos A, Genesca J, et al. beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393(10181):1597\u2013608.","journal-title":"Lancet"},{"issue":"21","key":"10160_CR18","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353(21):2254\u201361.","journal-title":"N Engl J Med"},{"issue":"6","key":"10160_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00261-015-0391-2","volume":"40","author":"AA Razek","year":"2015","unstructured":"Razek AA, Massoud SM, Azziz MR, El-Bendary MM, Zalata K, Motawea EM. Prediction of esophageal varices in cirrhotic patients with apparent diffusion coefficient of the spleen. Abdom Imaging. 2015;40(6):1465\u20139.","journal-title":"Abdom Imaging"},{"issue":"1","key":"10160_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejrad.2009.10.012","volume":"78","author":"AA Razek","year":"2011","unstructured":"Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol. 2011;78(1):129\u201334.","journal-title":"Eur J Radiol"},{"issue":"11","key":"10160_CR21","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3748\/wjg.v25.i11.1366","volume":"25","author":"T Besheer","year":"2019","unstructured":"Besheer T, Elalfy H, Abd El-Maksoud M, et al. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus. World J Gastroenterol. 2019;25(11):1366\u201377.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10160_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ferlitsch A, Payer BA, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58(5):911\u201321.","journal-title":"J Hepatol"},{"issue":"5","key":"10160_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.5009\/gnl16478","volume":"11","author":"YL Lim","year":"2017","unstructured":"Lim YL, Kim MY, Jang YO, Baik SK, Kwon SO. Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy for the reduction of portal pressure: an open randomized controlled pilot study. Gut Liver. 2017;11(5):702\u201310.","journal-title":"Gut Liver"},{"issue":"9","key":"10160_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMra0901512","volume":"362","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362(9):823\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"10160_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2036.2010.04308.x","volume":"32","author":"P Sharma","year":"2010","unstructured":"Sharma P, Kumar A, Jha S, Mishra SR, Sharma BC, Sarin SK. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther. 2010;32(1):105\u201312.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10160_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5009\/gnl.2007.1.2.159","volume":"1","author":"KT Suk","year":"2007","unstructured":"Suk KT, Kim MY, Park DH, et al. Effect of propranolol on portal pressure and systemic hemodynamics in patients with liver cirrhosis and portal hypertension: a prospective study. Gut Liver. 2007;1(2):159\u201364.","journal-title":"Gut Liver"},{"issue":"7","key":"10160_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead JA, Rajoriya N, Tehami N, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015;64(7):1111\u20139.","journal-title":"Gut"},{"issue":"6","key":"10160_CR28","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2016.01.031","volume":"64","author":"BS Madsen","year":"2016","unstructured":"Madsen BS, Nielsen KF, Fialla AD, Krag A. Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters. J Hepatol. 2016;64(6):1455\u20136.","journal-title":"J Hepatol"},{"issue":"3","key":"10160_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","volume":"64","author":"RP Mookerjee","year":"2016","unstructured":"Mookerjee RP, Pavesi M, Thomsen KL, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64(3):574\u201382.","journal-title":"J Hepatol"},{"issue":"2","key":"10160_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.amjms.2015.11.018","volume":"351","author":"AW Aday","year":"2016","unstructured":"Aday AW, Mayo MJ, Elliott A, Rockey DC. The beneficial effect of beta-blockers in patients with cirrhosis, portal hypertension and ascites. Am J Med Sci. 2016;351(2):169\u201376.","journal-title":"Am J Med Sci"},{"issue":"1","key":"10160_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","volume":"67","author":"R Sinha","year":"2017","unstructured":"Sinha R, Lockman KA, Mallawaarachchi N, Robertson M, Plevris JN, Hayes PC. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J Hepatol. 2017;67(1):40\u20136.","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10160-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T03:12:59Z","timestamp":1621825979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10160"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10160-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study protocol was approved by the Institutional Review Boards of all participating centers (CR317022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}